Fierce Pharma publisher Rebecca Willumson caught up with ixlayer’s General Manager of Biopharma, Matthew Walsh, at Digital Pharma East 2025 for a quick interview about the current and future state of pharma marketing.
The Fragmented Middle: Why Patient Momentum Breaks After Intake The front door of a patient
Connection to care is the new bar in direct-to-patient Biopharma direct-to-patient operators have become good
From Awareness to Care Progression: Why the Funnel Isn’t Fixed at the First Click Biopharma
Moving Pharmacy Upstream: The Strength of Earlier Pharmacy Integration For pharmaceutical marketers, campaign performance often
The Fragmented Middle: Why Patient Momentum Breaks After Intake The front door of a patient program can look polished—clean onboarding,
Connection to care is the new bar in direct-to-patient Biopharma direct-to-patient operators have become good at one part of the
From Awareness to Care Progression: Why the Funnel Isn’t Fixed at the First Click Biopharma teams know how to generate
